Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for OCGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 -0.587M
March 31, 2026 -34.98M
December 31, 2025 -1.002M
September 30, 2025 -18.51M
June 30, 2025 -0.061M
March 31, 2025 1.245M
December 31, 2024 -0.981M
September 30, 2024 -34.79M
June 30, 2024 -0.045M
March 31, 2024 0.145M
December 31, 2023 -0.016M
September 30, 2023 0.035M
June 30, 2023 -14.91M
March 31, 2023 -5.558M
December 31, 2022 -8.118M
September 30, 2022 -0.514M
June 30, 2022 -0.284M
March 31, 2022 -50.10M
December 31, 2021 -0.605M
September 30, 2021 -0.11M
June 30, 2021 -93.67M
March 31, 2021 -26.30M
December 31, 2020 -10.74M
September 30, 2020 -10.04M
June 30, 2020 -15.57M
Date Value
March 31, 2020 0.00
December 31, 2019 -23.33M
September 30, 2019 0.6494M
June 30, 2019 -1.00M
March 31, 2019 0.00
December 31, 2018 -0.7412M
September 30, 2018 6.371M
June 30, 2018 -0.002M
March 31, 2018 -5.628M
December 31, 2017 -0.001M
September 30, 2017 -0.005M
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.044M
September 30, 2016 -27.68M
June 30, 2016 0.001M
March 31, 2016 -0.001M
December 31, 2015 0.001M
September 30, 2015 -0.027M
June 30, 2015 -0.013M
March 31, 2015 -4.738M
December 31, 2014 -59.40M
September 30, 2014 0.803M
June 30, 2014 -9.935M
March 31, 2014 0.235M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. -10.49M
Biogen, Inc. -6.00M
Gilead Sciences, Inc. 346.00M
MannKind Corp. -0.924M
Vertex Pharmaceuticals, Inc. 421.80M